Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 9, Issue 2, 2008, Pages 122-126

  Karantza, Maria V ^a,b   Mittelman, Steven D ^a,b   Dorey, Fred ^a   Samie, Sara ^a,b   Kaiserman, Kevin ^a,b   Halvorson, Mary ^a,b   Kaufman, Francine R ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REFERENCE VALUE; RISK ASSESSMENT; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGE OF ONSET; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; PATIENT SELECTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 42449097656     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00306.x     Document Type: Article

References (22)

1. Donahue RP, Orchard TJ. Diabetes mellitus and macrovascular complications: An epidemiological perspective. Diabetes Care 1992: 15: 1141-1155.
2. Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, II: Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999: 16: 466-471.
3. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattingey WA, for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1999: 338: 1650-1656.
4. Newman W, Freedman D, Voors A et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. N Engl J Med 1986: 314: 138-144.
5. Berenson GS, Srinivasan SR, Webber LS et al. Cardiovascular risk factors in children - update on the Bogalusa Heart Study. Primary Cardiol 1990: 16: 61-72.
6. Strong JP, Malcom GT, McMahan CA et al., for the Pathobiological Determinants of Atherosclerosis in Youth Research Group (PDAY). Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999: 281: 727-735.
7. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations. JAMA 1990: 264: 3018-3024.
8. Orchard TJ, Forrest KY-Z, Kuller LH, Becker DJ. Lipid and blood pressure treatment goals for type 1 diabetes. Diabetes Care 2001: 24: 1053-1059.
9. Krantz JS, Mack WJ, Hodis HN, Liu C-R, Lui C-H, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 2004: 145: 452-458.
10. Pai JK, Pischon T, Ma J et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004: 351: 2599-2610.
11. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998: 97: 2007-2011.
12. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001: 285: 2486-2497.
13. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 2004: 112: 378-382.
14. Hayaishi-Okano R, Yamasaki Y, Katakami N et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002: 25: 1423-1438.
15. Kilpatrick ES, Keevil BG, Jagger C, Spooner RJ, Small M. Determinants of raised C-reactive protein concentration in type 1 diabetes. Q J Med 2000: 93: 231-236.
16. Schram MT, Chaturvedi N, Schalkwijk CG et al. Vascular risk factors and markers of inflammation as determinants of inflammatory markers in type 1 diabetes - the EURODIAB Prospective Complications Study. Diabetes Care 2003: 26: 2165-2173.
17. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CDA. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular diseases in type 1 diabetes - the EURODIAB Prospective Complications Study. Diabetologia 2005: 48: 370-378.
18. Ladeia AM, Stefanelli E, Ladeia-Frota C, Moreira A, Hiltner A, Adan L. Association between elevated C-reactive protein and triglyceride levels in young subjects with type 1 diabetes. Diabetes Care 2006: 29: 424-426.
19. Wu T, Dorn JP, Donahue RP, Sempos CT, Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin. Am J Epidemiol 2002: 155: 65-71.
20. King D, Mainous A III, Buchanan T, Pearson W. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 2003: 26: 1535-1539.
21. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes management on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 1999: 48: 383-390.
22. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid artery intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003: 348: 2294-2303.